Mechanisms of metformin influence on the nitrogen oxide system investigation at experimental insulin resistance in rats
DOI:
https://doi.org/10.24959/ubphj.17.103Keywords:
insulin resistance, metformin, endothelium, nitric oxideAbstract
Topicality. Cardiovascular complications are among the leading causes of death in the world. It is known that diseases associated with insulin resistance, are often accompanied by endothelial dysfunction and cardiovascular continuum.
Aim. It is reasonable to investigate metformin mechanisms effect on the functional state of endothelium at experimental insulin resistance.
Materials and methods. The syndrome of insulin resistance was designed on Wistar rats – males by mass of a 180-220 g and age 3 months in the beginning of experiment, by daily long period intraperitoneal Dexamethazonum injections in low doses (15 mg/kg) in low-calorie diet conditions (29 % fats – predominantly saturated lipids ), rich in fructose (1 g per day per 100 g of body weight) (water solution ) over 5 weeks.
Results and discussion. The results indicate that in a model pathology group on 5 week of experiment, metformin significantly increases the total content of nitrates and nitrites and mediates a moderate, but significant increase in levels
of citrulline, with a slight decrease in the arginine content.
Conclusions. The article presents the biochemical results mechanisms of influence on the nitrogen oxide system by the oral hypoglycemic agent metformin experimental investigation at experimental insulin resistance in rats. This pattern of changes suggests a clinically significant influence of metformin on endothelium functional state that can be interpreted as a manifestation of endothelium protection properties.
References
Guo, S. Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms / S. Guo // J. of Endocrinol. –
– Vol. 220, Issue 2. – С. Т1–Т23. doi : 10.1530/joe–13–0327.
Eringa, E. Endothelial dysfunction in (pre) diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes / E. Eringa,
E. Serne, R. Meijer // Rev. in Endocrine and Metabolic Disorders. – 2013. – Vol. 14, Issue 1. – С. 39–48. doi : 10.1007/s11154–013–9239–7.
Jia, G. Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk / G. Jia, J. Sowers // Hypertension.
– 2014. – Vol. 64, Issue 4. – С. 1192–1193. doi : 10.1161/hypertensionaha.114.04348.
Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management / K. Tziomalos, V. Athyros, A. Karagiannis, D. Mikhailidis
// Nutrition, Metabolism and Cardiovascular Dis. – 2010. – Vol. 20, Issue 2. – С. 140–146. doi : 10.1016/j.numecd.2009.08.006.
Metformin: from mechanisms of action to therapies / M. Foretz, G. Bruno, B. Luc et al. // Cell Metabolism. – 2014. – Vol. 20, Issue 6. – С. 953–966.
doi : 10.1016/j.cmet.2014.09.018.
Role of AMP–activated protein kinase in mechanism of metformin action / G. Zhou, M. Robert, L. Ying et al. // The J. of Clin. Investigation. – 2001. –
Vol. 108, Issue 8. – С. 1167–1174. doi : 10.1172/jci200113505.
Rena, G. Molecular mechanism of action of metformin: old or new insights? / G. Rena, R. Ewan, S. Kei // Diabetologia. – 2013. – Vol. 56, Issue 9. –
С. 1989–1906. doi : 10.1007/s00125–013–2991–0.
The antidiabetic drug metformin activates the AMP–activated protein kinase cascade via an adenine nucleotide–independent mechanism / S. Hawley,
E. Anne, S. Grith, H. Grahame // Diabetes. – 2002. – Vol. 51, Issue 8. – С. 2420–2425. doi : 10.2337/diabetes.51.8.2420.
Cellular and molecular mechanisms of metformin: an overview / B. Viollet, G. Bruno, S. Nieves et al. // Clin. Sci. – 2012. – Vol. 122, Issue 6. –
С. 253–270. doi : 10.1042/cs20110386.
Загайко, А. Л. Модифікація методу моделювання експериментальної інсулінорезистентності у щурів : інформ. лист Міністерства охоро-
ни здоров’я України / А. Л. Загайко, T. O. Брюханова, А. І. Шкапо // Український центр наукової медичної інформації та патентно–ліцензійної роботи (Укрмедпатентінформ). – K., 2015. – № 86. – 7 с.
Matthews, D. Homeostasis model assessment: insulin resistance and b–cell function from fasting plasma glucose and insulin concentrations in
man / D. Matthews, J. Hosker, A. Rudenski // Diabetol. – 1985. – Vol. 28, Issue 7. – С. 412–419. doi : 10.1007/bf00280883.
Колб, В. Справочник по клинической химии / В. Колб, В. Камышников. – Мн : Беларусь, 1982. – 366 c.
Лифшиц, В. Биохимические анализы в клинике / В. Лифшиц, В. Сидельников. – Воронеж : Дом ВГУ, 1996. – 280 c.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
